Login  |  Register

Gilead Trial with Sofosbuvir & GS-5816 - Hepatitis C - MedHelp

Gilead Sciences: Twelve week Phase 2 trial of sofosbuvir + GS-5816 (without ribavirin or interferon) for genotypes 1, 2, and 3 treatment-naïve.

Alexa Traffic